Bone Biologics Corporation
BBLG
$2.16
-$0.04-1.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 184.74% | -14.90% | 9.86% | -19.90% | -66.72% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.62% | -27.06% | -27.25% | -78.29% | -65.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -67.86% | -36.44% | -21.50% | -- | -- |
| Total Current Assets | 119.26% | -17.65% | 3.31% | -18.30% | -58.11% |
|
|
|||||
| Total Current Assets | 119.26% | -17.65% | 3.31% | -18.30% | -58.11% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 119.26% | -17.65% | 3.31% | -18.30% | -58.11% |
|
|
|||||
| Total Accounts Payable | 74.08% | 69.49% | 3.41% | -82.76% | -86.27% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -95.44% | -82.07% | -99.00% | 3.48% | -78.19% |
| Total Other Current Liabilities | -95.44% | -82.07% | -99.00% | 3.48% | -78.19% |
| Total Current Liabilities | 42.74% | 52.61% | -54.57% | -76.89% | -85.26% |
|
|
|||||
| Total Current Liabilities | 42.74% | 52.61% | -54.57% | -76.89% | -85.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 42.74% | 52.61% | -54.57% | -76.89% | -85.26% |
|
|
|||||
| Common Stock & APIC | 9.25% | 4.10% | 5.60% | 4.98% | 2.81% |
| Retained Earnings | -5.11% | -5.21% | -5.08% | -5.22% | -6.61% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 126.75% | -20.79% | 19.86% | -0.02% | -48.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 126.75% | -20.79% | 19.86% | -0.02% | -48.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.75% | -20.79% | 19.86% | -0.02% | -48.90% |
|
|
|||||